Vacunas

Children starting the series on time should receive a 5-dose series of DTaP vaccine at ages 2, 4, 6, 15 through 18 months, and 4 through 6 years. The fourth dose may be received as early as age 12 months, provided at least 6 months have elapsed since the third dose.

If the fourth dose of DTaP was administered at age 4 years or older, the fifth (booster) dose of DTaP vaccine is not necessary.

For children born prior to 1/1/2005, doses of DT and Td meet the immunization requirement for diphtheria toxoid-containing vaccine.

Children ages 7 through 10 years who are not fully immunized with the childhood DTaP vaccine series should receive Tdap vaccine as the first dose in the catch-up series; if additional doses are needed, use Td vaccine. For these children, the required 6th grade adolescent Tdap vaccine should not also be given.

For previously unvaccinated children 7 years of age and older, the immunization requirement is 3 doses. Tdap should be given for the first dose, followed by 2 doses of Td in accordance with the ACIP-recommended immunization schedule for persons 0-18 years of age.

Tdap can be received regardless of the interval since the last tetanus and diphtheria toxoid-containing vaccine.

For children enrolling in grades 6 through 12 who received a dose of Tdap at 7 years of age or older, the booster dose of Tdap is not required.

Day Care, Head Start- Children who start the series on time should receive a Hib vaccine primary series and a booster dose to all infants. The primary series doses should be received at 2, 4, and 6 months of age. One booster dose should be received at age 12 through 15 months.

If the first dose was administered at ages 7 through 11 months, a second dose should be received at least 4 weeks later and a final dose at 12 through 15 months of age.

If 2 doses of vaccine were administered at 11 months of age or younger, a third and final dose should be received at 12 through 15 months of age and at least 8 weeks after the second dose.

If dose 1 was administered at ages 12 through 14 months, a final dose should be received at least 8 weeks after dose 1.

For children who received 1 dose of vaccine at 15 months of age or older, no further doses are necessary.

For unvaccinated children 15 months of age or older, 1 dose of vaccine is required.

Hib vaccine is not routinely required for children 5 years of age or older.

Children starting the series on time should receive a series of PCV13 vaccine at ages 2, 4, 6 months with a booster at age 12 through 15 months.

Unvaccinated children 7 through 11 months of age should receive 2 doses, at least 4 weeks apart, followed by a 3rd dose at age 12 through 15 months.

Unvaccinated children 12 through 23 months of age should receive 2 doses of vaccine at least 8 weeks apart.

Previously unvaccinated children 24 through 59 months of age should receive only 1 dose.  

PCV13 is the preferred vaccine for use in healthy unvaccinated/partially vaccinated children 2 through 59 months of age. A single supplemental dose of PCV13 is recommended for children 14 through 59 months who have already completed the age appropriate series of PCV7

2 doses.

The first dose of varicella vaccine should be received at age 12 through 15 months, and the second dose at age 4 through 6 years. The second dose may be received before age 4 years, provided at least 3 months have elapsed since the first dose.

If the second dose was administered at least 4 weeks after the first dose, it can be accepted as valid.